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Automatic individual arterial input functions calculated from PCA outperform 








To introduce a segmentation method to calculate an automatic arterial input function (AIF) 
based on principal component analysis (PCA) of dynamic contrast enhanced MR (DCE-
MR) imaging and compare it with individual manually-selected and population-averaged 
AIFs using calculated pharmacokinetic parameters. 
 
Materials and Methods 
The study included 65 individuals with prostate examinations (27 tumors and 38 controls). 
Manual AIFs were individually extracted and also averaged to obtain a population AIF. 
Automatic AIFs were individually obtained by applying PCA to volumetric DCE-MR 
imaging data and finding the highest correlation of the PCs with a reference AIF. 
Variability was assessed using coefficients of variation and repeated measures tests. The 
different AIFs were used as inputs to the pharmacokinetic model and correlation 
coefficients, Bland-Altman plots and ANOVA tests were obtained to compare the results.  
 
Results 
Automatic PCA-based AIFs were successfully extracted in all cases. The manual and PCA-
based AIFs showed good correlation (r between pharmacokinetic parameters ranging from 
0.74 to 0.95), with differences below the manual individual variability (RMSCV up to 
27.3%). The population-averaged AIF showed larger differences (r from 0.30 to 0.61). 
 
Conclusion 
The automatic PCA-based approach minimizes the variability associated to obtaining 
individual volume-based AIFs in DCE-MR studies of the prostate. 
 
Keywords 







The pharmacokinetic modeling of dynamic contrast-enhanced magnetic resonance (DCE-
MR) imaging is used to provide quantitative measurements of the microvascular perfusion 
properties of different tissues and biological situations, with a focus on the characterization 
of tumors and treatment response (1). To quantify the pharmacokinetic parameters, it is 
necessary to select a vascular function as input to the model, called the arterial input 
function (AIF). To incorporate this AIF data, several approaches have been proposed, such 
as reference experimentally derived AIFs (2,3), manual selection of individual AIFs (4,5), 
population-averaged AIFs (4-7) or automatically extracted personalized AIFs (8-11). 
Several of these studies have demonstrated that the quantitative parameters obtained from 
these models do not show significant differences based on how the AIF is selected (4-6). 
However, other studies report lower or very weak agreement (12,13). 
This methodological variability hinders the process of standardizing a final methodology. 
However, there are also important efforts to provide reasonable degrees of standardization, 
such as the Quantitative Imaging Biomarkers Alliance (QIBA), an initiative of the 
Radiological Society of North America. In their DCE MR imaging Quantification Profile 
(14), they propose three alternatives to extract the AIF. The best recommendation about the 
calculation of the AIF is to use an automatically extracted AIF. As a second option, they 
recommend the manual selection, as described by Vonken et al. (15). However, this method 
has significant variability due mainly to flow artifacts. The last recommendation is about 
those situations where it is not possible to obtain an AIF because of anatomy, motion, flow 
artifacts or T2* effects. In these cases, population-averaged or reference AIFs could be 
used. However, an average AIF does not take into account the individual hemodynamics, 
thus losing the ability to characterize individual patients in a more accurate way. Also, with 
image processing and automatic volume-based approaches, the previous limitations can be 
overcome, at least partially.   
The preferred methodology to decrease biases would allow the automatic extraction of the 
AIF without variability. With regard to this approach, several authors have proposed 
different solutions. Rijpkema et al. (8) proposal is based on the detection of early arrival of 
contrast media and thresholding the value of gadolinium concentration through an iterative 
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process; Singh et al. (9) used an approach based on thresholds with correction of partial 
volume effects; Shi et al. (10) proposed an iterative clustering algorithm called affinity 
propagation; Lin et al. (16) used a blind source separation algorithm to identify those 
voxels with the maximum arterial purity; and Kim et al. (11) developed an algorithm to 
select those voxels with similar contrast concentration homogeneity, allowing to select AIF 
voxels based on the well-known AIF profile and then correcting for partial volume effects. 
These methods vary in complexity, some of them being tested on very limited populations 
and thus, far from clinical validation. Also, they often concentrate on single slices, while it 
has been demonstrated that the choice of a certain slice has an important effect on the AIF 
selection and pharmacokinetic calculations (17).  
In this context of automatically extracted personalized AIFs, we propose a simple method 
based on principal component analysis (PCA) to extract with minimum variability those 
voxels with a pure arterial behavior from a volumetric DCE-MR imaging data set of 
individual patients.  
PCA (18) is a widespread statistical technique for the analysis of large data sets, which may 
have redundant information. This analysis allows a fast extraction of the sources of 
variation from large numbers of intensity vs. time curves, i.e. whole volumes analyzed on a 
voxel basis but taking all the data as a whole (19), hence taking profit of the correlation 
between pixels with the same behaviors. The output of PCA is a series of linearly 
uncorrelated latent variables called principal components (PC), which can be related to the 
expected dynamic behaviors of blood flow in organs and tissues; such as those used as 
schemes to categorize enhancement curves in types, i.e. 3-time-point method (20). When 
applying PCA to a whole volume of DCE-MR images, it can be demonstrated that the three 
largest sources of variation are usually associated to the arteries, normal enhancing organs 
and highly arterialized areas (19). The order of importance may change, depending on the 
relative contribution of these components to the whole volume of data.  
We hypothesize that the combination of PCA and a priori knowledge of a typical AIF 
behavior can be used to segment voxels from which to compute individual AIFs without 
user intervention. The aim of this work is to introduce this methodology in a clinically 
relevant setting and compare it with manual individual selection and population-averaged 




MATERIALS AND METHODS 
 
Patients 
Sixty-five patients (age 62 ± 9 years old, mean ± standard deviation) who underwent 
routine DCE-MR examinations of the prostate were retrospectively included in the study. 
Among them, 27 patients had pathological confirmation of prostate carcinoma while 38 had 
negative biopsy with 6 months follow up without lesions. All the 65 cases were used for 
AIF calculations and comparisons. 
In order to assess the performance of each AIF determination method to separate tumor 
from healthy tissue, a subgroup of 20 patients was defined. They were classified into 
healthy (10) and tumor (10). The criteria for the healthy group were negative biopsy, 
absence of family history of prostate cancer and stable PSA below 2.5 ng/ml (in at least two 
controls). The criteria for the tumor group were positive biopsy, PSA higher than 10 ng/ml, 
Gleason score higher than 7 and clinical status higher than T2a. For simplicity, only 
patients with tumor reliably located in the peripheral gland were included in this subgroup. 
All patients gave written consent for the inclusion of their anonymized data in the study. 
Approval from the Ethics Review Board was obtained for this study. 
 
Image acquisition 
The MR perfusion images were acquired in a 3 Tesla system (Philips Healthcare, Best, The 
Netherlands) with an 8-channel receiving surface coil and a 3D T1-weighted spoiled 
gradient echo sequence with the following parameters: TR / TE / FA = 3.4 ms / 1.7 ms / 
40º, full prostate coverage (12 slices), matrix size = 192 x 192, reconstructed voxel size = 2 
mm x 2 mm x 4 mm, temporal resolution of 3.4 s per dynamic, 80 dynamics (non-equally 
spaced), total acquisition time of 5 min, contrast agent Gd-DOTA (Dotarem®, Guerbet, 
France) and contrast dose 0.2 ml/kg followed by 40 ml of saline flush at 4 ml/s, using a 
power injector. 
Also, a specific gradient echo with multiple flip angle sequence was acquired to obtain 
voxel-wise prostate T1 mapping calculations for the conversion of intensity values into 
contrast concentration measurements. The same geometry and characteristics as in the DCE 
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sequence were used, except for TR / TE / FAs = 3 ms / 2 ms / (2º, 7º, 10º, 20º, 30º, 40º, 
50º). The multitransmit technology was used in order to obtain B1 mapping and minimize 
flip angle variations. 
Finally, T2-weighted images were used to characterize prostate morphology and locate 
suspicious hypointense areas, with the following: 2D turbo spin echo sequence, ETL = 17, 
TR / TE / FA = 3858 ms / 90 ms / 90º and voxel size: 0.5 mm x 0.5 mm x 2 mm. 
 
Image analysis 
Selection of the AIFs 
Individual manual selection and variability assessment 
For every case, a radiologist (RP, 8 years of experience), manually drew a ROI on the right 
external iliac artery of the central slice. The AIF was obtained after averaging this ROI at 
each time point.  
The variability was obtained by repeating the measures with a separation of one week and 
calculating the differences between the pharmacokinetic parameters using manually 
selected AIFs in 10 random cases, Four sources of variability were considered. 
1. Selection of the AIF at the same location. The same radiologist selected the AIF at the 
right external iliac artery on the central slice after one week. 
2. Different location within the same slice. A random AIF was selected at the central slice, 
either choosing the right/left internal/external iliac arteries. 
3. Multiple manual ROIs per patient to obtain the individual AIF. To do this, the user 
drew 3 different ROIs instead of only one, again in the central slice and for a given 
artery (i.e. right external). Then these ROIs were averaged among themselves at each 
time point to calculate the individual AIF. To avoid influencing consecutive selections, 
the ROIs were not visible anymore once they had been selected. 
4. Selection of the AIF from the same artery at different slices. The AIF was extracted 






To obtain the population-averaged AIF, all the individual AIFs selected at the right external 
iliac artery of the central slice were adjusted to correct for differences in onset times, 
ensuring that the peaks were matched in time before averaging the curves.  
 
Automatic PCA-based AIF 
PCA (18) is an orthogonal linear mathematical transformation that generates a new 
coordinate system from a data set, so that the coordinates of the new system (PCs) model 
the variance of the data in decreasing order, ensuring that all PCs are linearly uncorrelated.  
In this study, PCA was applied to all the signal intensity curves of the DCE-MR volume. 
To do this, the original DCE-MR data were re-organized as a 2-dimension matrix X = (r x 
t), where r corresponds to the total number of observations (i.e. voxels) and t to variables 
(time steps). In this study, the matrix X had a size of 368640 (192x192x10) rows 
(observations) and 47 columns (t = 47). Notice that the extreme slices were excluded from 
the analysis as they can contain 3D spoiled gradient echo artifacts (this is demonstrated and 
discussed later on). 
Mathematically, PCA solves this matrix system: 
X = T · P’ + E 
where X are the observations; T are the scores, which is the representation of X in the PC 
coordinate system; P’ are the coefficients (also known as loadings) of each PC; and E is a 
residual matrix. Quantitatively, the PCs are iteratively obtained by maximizing the 
variance, obtained as 
PCi’ · S · PCi 
where S is the covariance matrix of X.  
Once the model is built, the interpretation of the PC’s loadings allows identifying those 
uptake curves (i.e. voxels) that follow a certain pattern determined by the contribution of 
this pattern to the whole variance of the DCE-MR data set. The advantage of the AIF is that 
arterial blood follows a pattern quite distinct from the rest of uptake curves, so the voxels 
that have a strong correlation with the arterial-like PC (first pass with a fast upslope and 
fast washout) can be identified and located easily by looking for high scores in the 
corresponding PC.  
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In practice, although the arterial-like PC models a significant variance of the data set, a 
priori it cannot be known which PC it will correspond to, as PCA releases the components 
according to decreasing variance. This final order depends on each particular case. 
However, in our experience, the PC corresponding to the arterial-like behavior was always 
obtained within the three initial PCs.  
To detect which PC corresponded to the AIF, the population-averaged AIF obtained in this 
study was used as reference. Other type of synthetic or experimentally derived (3) AIF-like 
curves could also be used, as it was just necessary to include a valid AIF shape as a priori 
knowledge. The PCs were correlated with this AIF-like curve, and the PC releasing the 
highest correlation was selected as the arterial PC. Before calculating the correlation, the 
PCs and the reference AIF were automatically adjusted by matching the maximum values 
in time.  
Once the PC corresponding to the AIF was found, the voxels containing the purest 
contribution of this PC were located by unwrapping the 2D matrix X. The purest voxels 
were defined as those whose total signal contribution contained at least 95% of the selected 
PC, computed as the variance contribution of the selected PC to the whole signal intensity 
of the voxel. This threshold was robust enough to ensure that only pure arterial voxels were 
selected (i.e. they were all part of the iliac arteries), minimizing partial volume artifacts. 
Finally, the intensities of these voxels were averaged at each time point to obtain the AIF. 
By handling all the temporal information together, PCA allows extracting robust estimates 
of the AIF, taking into account the whole volume and therefore minimizing possible blood 
flow effects and ROI selection bias. 
Although no human interaction was needed to extract the PCA-based AIF, two sources of 
variability were also assessed: the percentage threshold of the arterial-like PC contribution 
to the AIF (50%, 60%, 70%, 80%, 90% and 95%) and the effect of choosing a different 




In all cases, the same radiologist (RP, 8 years of experience) manually segmented the 
prostate by peripherally drawing ROIs in the slices in which it was visible. Afterwards, 
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voxel-by-voxel enhancement curves were automatically extracted to perform a voxel-based 
pharmacokinetic analysis. 
Furthermore, manually selected ROIs were placed on the peripheral prostate glands of the 
subgroup of patients classified as healthy and tumor. For the healthy group, a representative 
sample of the peripheral gland was selected. For the tumor group, ROIs were carefully 
placed in the T2-weighted low signal intensity areas, corresponding to the region of 
positive biopsy location. The anatomic division of the prostate into sextants (left or right 
base, mid-gland or apex of the peripheral gland) was used as reference.  
 
Pharmacokinetic modeling 
The one-input two-compartment extended Tofts model was used (21), obtaining the 
pharmacokinetic parameters Ktrans (transfer constant), kep (washout constant),vp (vascular 
space fraction) and ve (interstitial space fraction). 
The concentration-time curves were obtained from the intensity-time curves by calculating 
the T1 variations with respect to pre-contrast T1 values after the injection of the contrast 
agent (22,23).  




In order to simplify the analysis and the results, for each patient a unique value of each 
pharmacokinetic parameter was handled, obtained by averaging the values of all the 
prostate voxels.  
To assess the variability associated to the selection of the manual individual AIFs, the root 
mean square coefficient of variation (RMSCV) and the ANOVA test of repeated measures 

















where N is the number of repeated measures (N=10), si is the standard deviation and xi  is 
the mean of each pair of measures. The RMSCV was used to assess the variability ranges 
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(low values meaning low variability), while the ANOVA looked for statistical significance 
in the differences. The same methods were used to assess the variability associated to the 
selection of the PCA-based AIF. 
To compare the manual, population-averaged, and PCA-based AIFs, the relationships 
among the different sets of pharmacokinetic parameters were obtained using the Pearson’s 
correlation coefficient and Bland-Altman plots. Case by case differences in absolute values 
were also assessed using ANOVA tests. A Student’s t-test was performed to analyze the 
differences between healthy and cancerous tissues. 
A p-value < 0.05 was considered statistically significant. When necessary, logarithmic data 
transformations were applied to ensure that data distributions were normal before applying 




Manual AIF variability assessment 
Table 1 reports the RMSCV of each parameter for the analysis of the variability associated 
to the manual individual selection of the AIF. Selecting and averaging multiple manual 
ROIs to obtain the AIF for a single patient showed the minimum variability for all the 
parameters (RMSCV from 1.9% to 2.9%), followed by the selection of the AIF at the same 
location (RMSCV from 9.6 to 15.2%). Finally, the variability associated to selecting 
different locations (i.e. arteries) within the same slice or to using the same artery at 
different slices was comparable, with different results depending on the pharmacokinetic 
parameter, but always higher than in the previous approaches (RMSCV from 13.6% to 
25.3% and from 11.3% to 27.3%, respectively).  
 
Population-averaged AIF 
The population-averaged AIF is shown in figure 1, along with the 95 and 5 percentiles of 
the 65 individual AIFs. The relative peak differences between the individual manually 





In all cases the PC associated to the AIF was obtained within the first three PCs. Figure 2 
shows an example with several PCs extracted after applying PCA to a whole volume of 
DCE-MR images and the corresponding AIF (for visualization purposes only the first three 
PCs are shown). It can be seen that in this example the third component is already modeling 
noise. Then, the PC containing the AIF behavior was successfully selected in all cases as 
the PC maximizing the correlation with the average AIF, the DCE-MR volume was 
thresholded and a 3D arterial tree was obtained to extract the AIF (figure 3).  
The choice of different percentages (50%, 60%, 70%, 80%, 90% and 95%) to threshold the 
AIF mask showed RMSCV of 10.1% for Ktrans, 3.4% for kep, 7.6% for ve and 13.3% for vp, 
with the ANOVA repeated measures test showing p-values of 0.215, 0.802, 0.534 and 
0.314, respectively. When focusing on thresholds of 80% or higher, the RMSCV were 
5.5%, 2.7%, 5.0% and 8.2%, respectively. 
The choice of a different number of slices to perform the PCA (4 central slices, 8 central 
slices, 10 central slices and whole volume) showed RMSCV of 47.9% for Ktrans, 20.9% for 
kep, 16.1% for ve and 13.7% for vp, with the ANOVA repeated measures test showing p-
values of 0.044, 0.213, 0.382 and 0.223, respectively. When the extreme slices were 
excluded from the analysis, the RMSCV fell drastically to 3.8% for Ktrans, 5.4% for kep, 
4.1% for ve and 5.7% for vp.  
The full process of applying PCA to the whole DCE-MR volume and finding the AIF took 
2.6±0.3 seconds (mean ± standard deviation), using a computer with an Intel® CoreTM i7 
@3.60 GHz and 32 GB of RAM memory, without parallel computing. 
 
Global comparison between the 3 AIFs 
Table 2 shows the Pearson’s correlations between the pharmacokinetic parameters obtained 
from each pair of AIFs. The highest correlations were found between the manual and the 
PCA-based AIFs, as they are both extracted from the same individual. The variations were 
caused by small differences in the height of the AIF peaks. On the other hand, the average 
AIF showed more disparities, both when compared to the manual and the PCA-based AIFs. 
Notice that ve was the parameter with the highest correlation among the three AIFs. 
After calculating the case-by-case differences (table 3), the individual AIFs (manual and 
automatic PCA-based) showed the lowest discrepancy in all the parameters, followed by 
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the differences between the average and PCA-based AIFs. Last, the largest differences were 
seen between the manual and the average AIFs. There were statistically significant 
differences between the manual and the average AIFs (p<0.001), and between the average 
and the PCA AIFs (p<0.001) for all the parameters, whereas no significant differences 
appeared between the manual and the PCA methods. 
When the differences in the AIF maximum (peak) values were analyzed together with the 
differences in the pharmacokinetic parameters on the same case-by-case basis, it was seen 
that the choice of the AIF had a direct effect on the pharmacokinetic parameters, especially 
when comparing the results of the average AIF with the other two AIFs (as figure 4 shows 
for Ktrans).  
Finally, the Bland-Altman plots (figure 5) showed a bias towards increasing differences 
between the resulting parameters as their estimated value increased (i.e. higher parametric 
values release larger differences between the different methods). This bias was more 
obvious when comparing the average AIF with the manual and PCA approaches, while it 
remained more constrained when comparing the manual and PCA AIFs. 
 
Diagnostic performance of the three AIFs 
Table 4 shows the pharmacokinetic parameters for each group of patients (healthy and 
tumor) using each AIF. kep and K
trans were the best parameters to separate between healthy 
and tumor tissue in the peripheral gland, showing statistically significant differences for the 
three AIFs (p-values ranging from 0.007 to 0.035). Qualitatively, kep showed a slightly 
better performance to separate healthy from tumor areas. Ktrans showed similar values in the 
healthy patients for the three AIFs, while it showed quite lower values for the tumor area 
when using the average AIF. On the contrary, kep showed lower values for the healthy area 
when using the manual AIF, while the values in the tumor were similar for the three AIFs. 
Figure 6 shows the parametric maps of Ktrans for one patient of each group, where the 
average AIF releases lower (tumor patient, 46% lower in comparison to the mean of the 
individual AIFs) or higher (healthy patient, 29% higher in comparison to the individual 







In this work, an automatic method is proposed to extract the AIF from a whole volume of 
DCE-MR images, taking into account a priori shape information from a population-
averaged AIF. The method is based on the application of PCA to the DCE-MR imaging 
data and the maximization of the correlation between each PC and the expected AIF 
behavior. Then the DCE-MR perfusion volume is thresholded ensuring that the segmented 
voxels have a very high contribution of the PC with the maximum correlation. Finally these 
voxels are averaged at each time point to release the individual PCA-based AIF. The 
method was tested on a relevant number of clinical studies, being robust and showing very 
low variability for all the cases. 
The reproducibility of the pharmacokinetic parameters obtained from DCE-MR images has 
been an issue for a long time, as the choice of the AIF is an important source of variability 
(24-26). In this work, we have shown that the variabilities associated to the manual 
selection of an AIF are not negligible.  
We have demonstrated that extracting an individual AIF by manually selecting and 
averaging several ROIs at the same locations showed the minimum variability. However, 
this method is more time consuming, and it does not prevent the differences obtained by 
selecting the AIF at different locations of the 3D data set (i.e. other arteries at the same 
slice or at different slices). Therefore, the lack of a validated protocol for the AIF manual 
selection when multiple choices are available poses difficult reproducibility issues. This 
enforces the need to consider whole volume automatic approaches to extract more accurate 
AIFs.  
The use of population-averaged AIFs has been proposed for those situations where it is not 
possible to obtain a proper AIF, due to the area under analysis or to image acquisition 
limitations (4). Several studies show that there are not important differences in comparison 
with the individual AIF (4-7,27), while other studies report weaker agreement between the 
results of the average and the individual AIFs (12), especially with important differences in 
Ktrans (13). In our study, we found that both approaches cannot be taken as equivalent, as 
the analysis of the case-by-case differences shows. On the other hand, we also found that 
after performing an ANOVA among the global results corresponding to each AIF, using the 
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original values instead of the differences (results not shown in the study), they were not 
statistically different. This shows that on a population-level analysis the results are 
equivalent, but not on an individual basis. 
The automatic PCA-based method was fast and robust and it showed very low variability to 
extract the AIF in all cases. The differences in the pharmacokinetic parameters compared to 
the manual individual AIF were below the range of manual selection variability. This 
suggests that the proposed approach can be used to obtain the AIF from a whole set of 
DCE-MR images without manual interaction and with accurate results, considering the 
expert manual selection as a ground truth. In this work, a 95% threshold was empirically set 
to obtain “pure” arterial behaviors, ensuring that it was highly selective with the voxels that 
were to be included as AIF. The effect of choosing a different threshold was also studied, 
demonstrating that there is also a relatively high variability when a lower threshold (~50%) 
is applied. The recommendation should be to set this threshold as high as possible (i.e. 90-
95%) to ensure a fully arterial behavior in the AIF. Notice also that as it was a volume-
based approach, the amount of candidate voxels was large enough to establish such high 
thresholds, so even if some arterial voxels were excluded from the selection, the sample 
was still sufficient to provide a robust AIF. 
Another source of bias for the calculation of the automatic PCA was the inclusion of the 
extreme slices in the analysis. In 3D spoiled gradient echo sequences, these slices can have 
artifacts due to aliasing or to an incorrect excitation profile, so they can introduce errors 
when PCA is performed on the whole volume. When they were excluded the variability 
decreased drastically. 
The diagnostic performance of each AIF was also studied by comparing the 
pharmacokinetic parameters of healthy tissue and tumors in the peripheral gland. In 
average, the three AIFs showed similar results, with relatively small differences and with 
Ktrans and kep as the best parameters to separate both tissues. Again, we hypothesized that 
two facts probably occur here. Regarding the range of values, although on a case-by-case 
scenario there are differences, the population analysis masks them, showing homogenized 
populations. Regarding the statistical separability between healthy tissue and tumor, the 
choice of one AIF or another probably introduces a scaling effect in the pharmacokinetic 
parameters (especially Ktrans), so that the relative differences between tissues are 
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nonetheless maintained. Therefore, as long as the AIF shape is preserved, this may not 
make a big difference for classifying tissues on an individual case. However, the lack of 
absolute individual measurements has limitations in order to obtain reference values.  
Our Ktrans values for the healthy tissue were in the range of those released by Chen et al. 
(28) for the peripheral zone (0.23±11 min-1). However, our values were quite higher for the 
tumor (0.57±0.18 min-1 in Chen et al.), and more in the range of the study by Vos et al. 
(29), focused only in the tumor (0.63 to 1.44 min-1, including low, intermediate and high-
aggressive tumors). Comparisons with other works are difficult, as they do not normally 
distinguish between peripheral and central prostate glands. 
Our study had several limitations. First, the PCA-based approach does not provide an 
organ-specific AIF, but the optimal AIF within the volume of DCE-MR images. In fact, 
more specific AIFs would require organ-specific reference AIFs, but probably with more 
variability associated to manual segmentation, due to spatial resolution restrictions. The 
selection of sub-volumes containing the arteries of interest could also help in obtaining 
more specific AIFs. A second limitation is the necessity to incorporate a priori knowledge 
of a standard AIF shape. However, as this type of shape is well known, it can be easily 
generated by mathematical models or incorporated as an empirical curve, such as in this 
work. Finally, the results of using analytical expressions for the AIF have not been explored 
(3,30-33). The comparison with these approaches was beyond the scope of this paper, 
considering that the MR studies had enough temporal resolution and a proper AIF could 
always be extracted from the volume of DCE-MR images. 
In conclusion, an automatic PCA-based AIF was successfully obtained in all cases. The 
pharmacokinetic parameters obtained by the manual and PCA AIFs were comparable, with 
the PCA AIF showing differences below the range of the variability associated to the 
manual AIF selection. The population-averaged AIF showed significantly different results 
in comparison to the manual and the PCA-based AIFs. Taking the expert manual selection 
of AIFs as reference and considering its variability sources, the automatic PCA-based 
approach should be preferred, as it is a fast method with very low variability to extract 






1. Leach MO, Brindle KM, Evelhoch JL, et al. The assessment of antiangiogenic and 
antivascular therapies in early-stage clinical trials using magnetic resonance imaging: 
issues and recommendations. Br J Cancer 2005;92:1599-1610. 
2. Tofts PS, Kermode AG. Measurement of the blood-brain barrier permeability and 
leakage space using dynamic MR imaging. I. Fundamental concepts. Magn Reson Med 
1991;17:357-367. 
3. Parker GJM, Roberts C, MacDonald A, et al. Experimentally-derived functional form 
for a population-averaged high-temporal-resolution arterial input function for dynamic 
contrast-enhanced MRI. Magn Reson Med 2006;56:993-1000. 
4. Meng R, Chang SD, Jones EC, Goldenberg SL, Kozlowski P. Comparison between 
population average and experimentally measured arterial input function in predicting 
biopsy results in prostate cancer. Acad Radiol 2010;17:520-525. 
5. Loveless ME, Halliday J, Liess C, et al. A quantitative comparison of the influence of 
individual versus population-derived vascular input functions on dynamic contrast 
enhanced-MRI in small animals. Magn Reson Med 2012;67:226-236.  
6. Shukla-Dave A, Lee N, Stambuk H, et al. Average arterial input function for 
quantitative dynamic contrast enhanced magnetic resonance imaging of neck nodal 
metastases. BMC Medical Physics 2009;9:4-12. 
7. Wang Y, Huang W, Panicek DM, Schwartz LH, Koutcer JA. Feasibility of using 
limited-population-based arterial input function for pharmacokinetic modeling of 
osteosarcoma dynamic contrast-enhanced MRI data. Magn Reson Med 2008;59:1183-
1189. 
8. Rijpkema M, Kaanders JHAM, Joosten FBM, Van der Kogel AJ, Heerschap A. Method 
for quantitative mapping of dynamic MRI contrast agents uptake in human tumors. J 
Magn Reson Imaging 2001;14:457-463. 
9. Singh A, Rathore RK, Haris M, Verma SK, Husain N, Gupta RK. Improved bolus 
arrival time and arterial input function estimation for tracer kinetic analysis in DCE-
MRI. J Magn Reson Imaging 2009;29:166-176. 
17 
 
10. Shi L, Wang D, Liu W, et al. Automatic detection of arterial input function in dynamic 
contrast enhanced MRI based on affinity propagation clustering. J Magn Reson Imaging 
2014;39:1327-1337. 
11. Kim JH, Im GH, Yang J, Choi D, Lee J, Lee JH. Quantitative dynamic contrast-
enhanced MRI for mouse models using automatic detection of the arterial input 
function. NMR Biomed 2012;25:647-684. 
12. Li X, Welch EB, Arlinghaus LR, et al. A novel AIF tracking method and comparison of 
DCE-MRI parameters using individual and population-based AIFs in human breast 
cancer. Phys Med Biol 2011;56:5753-5769. 
13. Fedorov A, Fluckiger J, Ayers GD, et al. A comparison of two methods for estimating 
DCE-MRI parameters via individual and cohort based AIFs in prostate cancer: a step 
towards practical implementation. Magn Reson Imaging 2014;32:321-329. 
14. DCE MRI Technical Committee. DCE MRI Quantification Profile, Quantitative 
Imaging Biomarkers Alliance. Version 1.0. Publicly Reviewed Version. QIBA, July 1, 
2012. Available from: RSNA.ORG/QIBA. 
15. Vonken EJ, Van Osch MJ, Bakker CJ, Viergever MA. Measurement of cerebral blood 
perfusion with dual-echo multi-slice quantitative dynamic susceptibility contrast MRI. J 
Magn Reson Imaging 1999;10:109-117. 
16. Lin Y, Chan T, Chi C, et al. Blind estimation of the arterial input function in dynamic 
contrast-enhanced MRI using purity maximization. Magn Reson Med 2012;68:1439-
1449. 
17. Roberts C, Little R, Watson Y, Zhao S, Buckley DL, Parker GJ. The effect of blood 
inflow and B(1)-field inhomogeneity on measurement of the arterial input function in 
axial 3D spoiled gradient echo dynamic contrast-enhanced MRI. Magn Reson Med 
2011;65:108-119. 
18. Jackson JE. A user’s guide to principal components. New York: John Wiley & Sons; 
1991. 575 p. 
19. Prats-Montalbán JM, Sanz-Requena R, Martí-Bonmatí L, Ferrer A. Application of 
multivariate image analysis techniques to prostate magnetic resonance perfusion 
studies. J Chemom 2014;28:672-680. 
18 
 
20. Eyal E, Bloch BN, Rofsky NM, et al. Principal component analysis of dynamic 
contrast-enhanced MRI in human prostate cancer. Invest Radiol 2010;45:174-181. 
21. Tofts PS. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson 
Imaging 1997;7:91-101. 
22. Donahue KM, Burstein D, Manning WJ, Gray WL. Studies of Gd-DTPA relaxivity and 
proton exchange rates in tissue. Magn Reson Med 1994;32:66-76. 
23. Taylor JS, Reddick WE. Evolution from empirical dynamic contrast-enhanced magnetic 
resonance imaging to pharmacokinetic MRI. Adv Drug Deliv Rev 2000;41:91-110. 
24. Port RE, Knopp MV, Brix G. Dynamic contrast-enhanced MRI using Gd-DTPA: 
interindividual variability of the arterial input function and consequences for the 
assessment of kinetics in tumors. Magn Reson Med 2001;45:1030-1038. 
25. Dale BM, Jesberger JA, Lewin JS, Hillenbrand CM, Duerk JL. Determining and 
optimizing the precision of quantitative measurements of perfusion from dynamic 
contrast enhanced MRI. J Magn Reson Imaging 2003;18:575-584. 
26. Garpebring A, Bynolfsson P, Yu J, et al. Uncertainty estimation in dynamic contrast-
enhanced MRI. Magn Reson Med 2013;69:992-1002. 
27. Onxley JD, Yoo DS, Muradyan N, MacFall JR, Brizel DM, Craciunescu OI. 
Comprehensive population-averaged arterial input function for dynamic contrast-
enhanced magnetic resonance imaging of head and neck cancer. Int J Radiat Oncol Biol 
Phys 2014;89:658-665. 
28. Chen YJ, Chu WC, Pu YS, Chueh SC, Shun CT, Tseng WY. Washout gradient in 
dynamic contrast-enhanced MRI is associated with tumor aggressiveness of prostate 
cancer. J Magn Reson Imaging 2012;36:912-919. 
29. Vos EK, Litjens GJ, Kobus T, et al. Assessment of prostate cancer aggressiveness using 
dynamic contrast-enhanced MRI at 3T. Eur Urol 2013;64:448-455. 
30. Yang C, Karczmar GS, Medved M, Oto A, Zamora M, Stadler W. Reproducibility 
assessment of a multiple reference tissue method for quantitative dynamic contrast-
enhanced MRI analysis. Magn Reson Med 2009;61:851-859. 
31. McGrath DM, Bradley DP, Tessier JL, Lacey T, Taylor CJ, Parker GJM. Comparison 
of model-based arterial input functions for dynamic contrast-enhanced MRI in tumor 
bearing rats. Magn Reson Med 2009;61:1173-1184. 
19 
 
32. Orton MR, D’Arcy JA, Walker-Samuel S, et al. Computationally efficient vascular 
input function models for quantitative kinetic modeling using DCE-MRI. Phys Med 
Biol 2008;53:1225-1239. 
33. Heisen M, Fan X, Buurman J, Van Riel NAW, Karczmar GS, Ter Haar Romeny BM. 
The use of a reference tissue arterial input function with low-temporal-resolution DCE-




Table 1. Manual AIF selection variability of the pharmacokinetic parameters obtained as 
the root mean square coefficient of variation (RMSCV) and the corresponding statistical 
significance of the ANOVA test with repeated measures. These values are obtained from 
repeating the manually selected AIF experiment in ten random cases, with a separation of 
one week between the analyses.  
 
 
AIF manual selection approach 
Same location 
Different 
location in the 
same slice 
3 averaged 






RMSCV 9.6% 18.7% 2.0% 27.3% 
ANOVA’s 
p-value 
0.043 0.202 0.076 0.002 
kep 
RMSCV 9.7% 13.6% 2.8% 11.3% 
ANOVA’s 
p-value 
0.288 0.035 0.416 0.873 
ve 
RMSCV 15.2% 25.3% 2.9% 24.7% 
ANOVA’s 
p-value 
0.033 0.035 0.675 0.001 
vp 
RMSCV 14.4% 23.7% 1.9% 14.5% 
ANOVA’s 
p-value 




Table 2. Pearson’s correlations (r) between the pharmacokinetic parameters obtained by 
each AIF estimation method with the statistical significance between brackets. 
 
 Manual vs. Average Manual vs. PCA Average vs. PCA 
Ktrans r=0.30 (p=0.015) r=0.87 (p<0.001) r=0.53 (p<0.001) 
kep r=0.32 (p=0.009) r=0.74 (p<0.001) r=0.62 (p<0.001) 
ve r=0.61 (p<0.001) r=0.95 (p<0.001) r=0.64 (p<0.001) 




Table 3. Results (mean and 95% confidence interval in brackets, in absolute values) 
showing the statistics of the case-by-case differences in the pharmacokinetic parameters 
between manual, average and PCA-based AIFs. The p-value represents the statistical 
significance of the comparisons between the groups of subtracted values. 
 
 (1) Manual-Average (2) Manual-PCA (3) Average-PCA p1-2 p1-3 p2-3 
Ktrans (min-1) 0.065 (0.049,0.086) 0.022 (0.016,0.030) 0.059 (0.044,0.079) <0.001 0.665 <0.001 
kep (min-1) 0.206 (0.157,0.273) 0.066 (0.050,0087) 0.153 (0.117,0.202) <0.001 0.135 <0.001 
ve 0.074 (0.055,0.101) 0.025 (0.018,0.033) 0.076 (0.056,0.103) <0.001 0.934 <0.001 





Table 4. Results (mean and 95% confidence interval in brackets) showing the descriptive 
and ANOVA statistics of the pharmacokinetic parameters for each group of patients 
(healthy and tumor) using each AIF. 
 
 AIF type Healthy Tumor p 
Ktrans (min-1) 
Manual 0.17 (0.08,0.26) 0.97 (0.48,1.46) 0.034* 
PCA-based 0.18 (0.10,0.26) 1.06 (0.52,1.61) 0.033* 
Averaged 0.16 (0.10,0.23) 0.75 (0.39,1.12) 0.035* 
kep (min
-1) 
Manual 0.44 (0.25,0.64) 2.09 (1.43,2.76) 0.007* 
PCA-based 0.82 (0.22,1.43) 2.20 (1.47,2.92) 0.014* 
Averaged 0.71 (0.19,1.24) 2.14 (1.36,2.93) 0.031* 
ve 
Manual 0.35 (0.17,0.53) 0.53 (0.35,0.71) 0.173 
PCA-based 0.32 (0.11,0.54) 0.54 (0.38,0.70) 0.091 
Averaged 0.22 (0.12,0.32) 0.41 (0.31,0.50) 0.017* 
vp 
Manual 0.01 (0.01,0.02) 0.01 (0.00,0.02) 0.358 
PCA-based 0.01 (0.01,0.02) 0.01 (0.00,0.02) 0.470 






Figure 1. Population-averaged AIF obtained at the external iliac arteries of the 65 patients. 
All curves were corrected for onset times before averaging. The continuous line shows the 
average and the dashed lines the 95- and 5-percentile. 
Figure 2. Principal components (PCs) obtained from the PCA of all the DCE-MR images. 
First three PCs: PC1 corresponds to the typical behavior of an artery, PC2 represents a 
typical slow progressive enhancement and PC3 corresponds to noise. The order may vary 
according to the explained variance of each PC. In some cases, PC3 still models a 
physiologically relevant behavior. 
Figure 3. Automatic volumetric segmentation of the purest arterial component based on the 
principal components analysis. (a) The segmented area corresponds to those voxels with the 
highest contribution of the arterial component (PC1 in figure 2), corresponding to the 
external iliac arteries. (b) The AIF is obtained by averaging the contributions of all voxels 
at each time point. 
Figure 4. Case-by-case analysis of the differences in Ktrans originated by differences in the 
maximum (peaks) of the AIFs. a) Manual vs. average AIFs. b) Manual vs. PCA-based 
AIFs. c) Average vs. PCA-based AIFs. The points in b) are more clustered, reflecting 
smaller differences than when comparing with the average AIF. 
Figure 5. Bland-Altman plots showing the mean and differences for Ktrans. a) Manual vs. 
averaged AIFs. b) Manual vs. PCA-based AIFs. c) Averaged vs. PCA-based AIFs. Both a) 
and c) show that the differences with the averaged AIF increase when the mean value of 
Ktrans increases. The differences between the manual and the PCA-based AIF are more 
bounded. 
Figure 6. Parametric colored map showing Ktrans overlapped on a T2-weighted image. Top 
row: a low signal intensity area can be seen on the left side of the peripheral gland related 
to the presence of a tumor (arrow). In this case, the average AIF was quite higher than the 
individual AIF of the patient, so the Ktrans values using the average AIF (a) were 
underestimated in comparison to those using the individual AIFs, being b) the manual AIF 
and c) the PCA-based AIF. For visualization purposes, the parametric maps show only 
Ktrans values higher than 0.2 min-1. Bottom row: in this case the average AIF was lower, 
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releasing higher values for Ktrans (d) in comparison to the individual (e) and PCA-based (f) 
AIFs, which showed similar results. 
 
